Feed CFOO
Summary
16 / 100 · Bulios Score
Valuation 0Growth 0Profitability 0Quality 57Debt 22Stability 13
What speaks for it
- It earns 32 CNY a year on every 100 CNY of invested capital.
- It holds more cash than debt: ¥108.1K against ¥105.1K.
What to watch
- Revenue fell by 97% a year over the last 3 years.
- The company made a loss over the last 12 months.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (CNY)
20212022202320242025
Diluted EPS (CNY)
20212022202320242025
Revenue fell by 89% a year over 5 years. Over the last 3 years it fell by 97% a year.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
YesCash and short-term investments ¥108.1K
Debt ¥105.1K
It holds more cash than debt. The debt score is low because of the debt-to-equity ratio.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Sales of Healthcare 79%
- Consultancy Service Fee Income 21%
By region
- CHINA 79%
- HONG KONG 21%
Sales of Healthcare brings in 79% of revenue.
Segments in detail